Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, 231 Atsunaka-chou, Fukuchiyama-city, Kyoto, 620-8505, Japan.
Department of Gastroenterology and Hepatology, Fukuchiyama City Hospital, 231 Atsunaka-chou, Fukuchiyama-city, Kyoto, 620-8505, Japan.
J Infect Chemother. 2022 Mar;28(3):413-419. doi: 10.1016/j.jiac.2021.11.025. Epub 2021 Dec 30.
Knowledge of the bacterial spectrum involved in acute cholangitis is essential for adequate empiric antibiotic treatment. There is a lack of published data comparative data between patients with first and recurrent episodes of acute cholangitis. This study aimed to analyze the microbial spectrum in patients with first and second episodes of acute cholangitis.
We retrospectively assessed 251 patients with first episodes of acute cholangitis between January 2014 to September 2020.
At the first episode of acute cholangitis, the predominant strains belonged to Escherichia coli (17.9%), followed by Klebsiella spp. (15.5%), Enterobacter spp. (6.4%), and Enterococcus spp. (5.6%). During follow-up, acute cholangitis recurred in 109 patients; at the second episode, the predominant strains belonged to Enterococcus spp. (35.8%), followed by Klebsiella spp. (27.5%), Enterobacter spp. (22.9%), and Escherichia coli (15.6%). Enterococcus spp. were the most common pathogen in patients with second episode of acute cholangitis, regardless of whether the cholangitis was caused by a malignant tumor or a benign disease.
Unlike in patients with a first episode of acute cholangitis, clinicians should consider empirical treatment with anti-enterococcal antibiotics in patients with recurrent episodes of acute cholangitis.
了解急性胆管炎涉及的细菌谱对于充分的经验性抗生素治疗至关重要。目前缺乏关于首次和复发性急性胆管炎患者之间比较数据的发表数据。本研究旨在分析首次和第二次急性胆管炎发作患者的微生物谱。
我们回顾性评估了 2014 年 1 月至 2020 年 9 月期间 251 例首次急性胆管炎患者。
首次急性胆管炎时,主要菌株属于大肠埃希菌(17.9%),其次是克雷伯菌属(15.5%)、肠杆菌属(6.4%)和肠球菌属(5.6%)。在随访期间,109 例患者急性胆管炎复发;第二次发作时,主要菌株属于肠球菌属(35.8%),其次是克雷伯菌属(27.5%)、肠杆菌属(22.9%)和大肠埃希菌(15.6%)。肠球菌属是第二次急性胆管炎患者最常见的病原体,无论胆管炎是由恶性肿瘤还是良性疾病引起。
与首次急性胆管炎患者不同,对于复发性急性胆管炎患者,临床医生应考虑使用抗肠球菌抗生素进行经验性治疗。